Leslie Trigg - Oct 1, 2021 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Executive Officer, Director
Signature
By: Nabeel Ahmed For: Leslie Trigg
Stock symbol
OM
Transactions as of
Oct 1, 2021
Transactions value $
-$1,945,056
Form type
4
Date filed
10/4/2021, 04:17 PM
Previous filing
Sep 20, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $58.6K +20K +7.98% $2.93 271K Oct 1, 2021 Direct
transaction OM Common Stock Sale -$974K -20K -7.39% $48.69 251K Oct 1, 2021 Direct F1, F2
transaction OM Common Stock Options Exercise $36.6K +12.5K +4.99% $2.93 263K Oct 1, 2021 Direct
transaction OM Common Stock Sale -$609K -12.5K -4.75% $48.71 251K Oct 1, 2021 Direct F1, F2
transaction OM Common Stock Options Exercise $29.3K +10K +3.99% $2.93 261K Oct 1, 2021 Direct
transaction OM Common Stock Sale -$487K -10K -3.84% $48.69 251K Oct 1, 2021 Direct F1, F2
holding OM Common Stock 8.77K Oct 1, 2021 Trigg Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -20K -21.77% $0.00 71.9K Oct 1, 2021 Common Stock 20K $2.93 Direct F3
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -12.5K -17.39% $0.00 59.4K Oct 1, 2021 Common Stock 12.5K $2.93 Direct F3
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -16.84% $0.00 49.4K Oct 1, 2021 Common Stock 10K $2.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.77 to $49.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vested in 48 equal monthly installments beginning on August 22, 2015.